Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer - Paul E. Hanna; Rajesh K. Anumolu; Shveta S. Motwani; Kevin L. Chen; Nurit Katz-Agranov; Olivia Green-Lingren; Osman A. Yilmam; Kenar D. Jhaveri; Abhijat Kitchlu; Jaya Kala; Meghan E. Sise; Shruti Gupta (Kidney International Reports)